3517-58-6 Usage
Physical state
Yellow crystalline solid
Common uses
Pharmaceutical industry
Potential therapeutic applications
Medicine and drug development
Structure
Isoindole-1,3(2H)-dione core with a 2-[3-(5-methoxy-2-nitrophenyl)-3-oxopropyl] substituent
Unique properties
The combination of the isoindole-1,3(2H)-dione core and the 2-[3-(5-methoxy-2-nitrophenyl)-3-oxopropyl] substituent give the compound its unique properties and potential pharmacological activity.
+ Physical state
The form in which a substance exists (solid, liquid, gas).
+ Pharmaceutical industry
An industry that focuses on the development, production, and marketing of drugs and medications.
+ Potential therapeutic applications
Possible uses of a compound in the treatment of diseases or medical conditions.
+ Medicine and drug development
The process of creating and testing new drugs and medications to treat or prevent diseases and medical conditions.
+ Structure
The arrangement of atoms in a molecule and the chemical bonds between them.
+ Unique properties
Characteristics that set a compound apart from other similar compounds.
+ Pharmacological activity
The interaction of a compound with living organisms, particularly its effects on biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 3517-58-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,5,1 and 7 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3517-58:
(6*3)+(5*5)+(4*1)+(3*7)+(2*5)+(1*8)=86
86 % 10 = 6
So 3517-58-6 is a valid CAS Registry Number.
3517-58-6Relevant academic research and scientific papers
Development of urea and thiourea kynurenamine derivatives: Synthesis, molecular modeling, and biological evaluation as nitric oxide synthase inhibitors
Chayah, Mariem,Carri?n, M. Dora,Gallo, Miguel A.,Jiménez, Rosario,Duarte, Juan,Camacho, M. Encarnaci?n
, p. 874 - 882 (2015/05/05)
Herein we describe the synthesis of a new family of kynurenamine derivatives with a urea or thiourea moiety, together with their in vitro biological evaluation as inhibitors of both neuronal and inducible nitric oxide synthases (nNOS and iNOS, respectivel
Kynurenamines as neural nitric oxide synthase inhibitors
Entrena, Antonio,Camacho, M. Encarnación,Carrión, M. Dora,López-Cara, Luisa C.,Velasco, Guillermo,Léon, Josefa,Escames, Germaine,Acu?a-Castroviejo, Dario,Tapias, Víctor,Gallo, Miguel A.,Vivó, Antonio,Espinosa, Antonio
, p. 8174 - 8181 (2007/10/03)
To find new compounds with potential neuroprotective activity, we have designed, synthesized, and characterized a series of neural nitric oxide synthase (nNOS) inhibitors with a kynurenamine structure. Among them, N-[3-(2-amino-5-methoxyphenyl)-3-oxopropy
